Grant for the support the development of MAP for self-administration of contraceptives
ltslohmann.com · 679 words · saved by 1 readers
Grant for the support the development of MAP for self-administration of contraceptives for women in low- and middle-income countries (LMICs)
Skip to content December 19, 2023 Andernach – LTS, a leading pharmaceutical technology company, announced today that it has received a grant from the Bill & Melinda Gates Foundation. The purpose of the grant is to support the development of microneedle array patches (MAP) for self-administration of contraceptives for women in low- and middle-income countries (LMICs). The grant will fund $4.3 million over a duration of 25 months. Poor access to contraceptives presents a significant burden for women living in LMICs. According to a 2022 study, one in 14 women worldwide who want to use…
saved by
related reading
- Anthropic forms $200 million partnership with the Gates Foundation \ Anthropicanthropic.com
- Cross-Border Impact Venturescrossborder.ventures
- Axmed - Accelerating Access to Medicines for Allaxmed.com
- Big Ideas in Tech for 2024 | Andreessen Horowitza16z.com
- Medical breakthroughs in 2025 - by Saloni Dattaniscientificdiscovery.dev
- Where are all the trillion dollar biotechs?ladanuzhna.xyz
- Multiply Labs | Robotic Biomanufacturing Infrastructuremultiplylabs.com
- New HIV Frontier: The Fight To Access Long-Acting Prevention Drugs - Health Policy Watchhealthpolicy-watch.news
- NewLimit raises $435M led by Founders Fund to bring longevity medicines to human trialsblog.newlimit.com
- Vaginal Drug Delivery Had A Funding Problem—Merck Changed Thatforbes.com
- Hard Drugs | Lenacapavir: The miracle drug that could end AIDSharddrugs.worksinprogress.co
- Drug Discovery for Menopause with Gero and AthenaBIOathenadao.substack.com